Molecular assessment of ovarian cancer in Latina patients
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study looks at tumor samples from patients with advanced ovarian, fallopian tube, or peritoneal cancer to understand the biology better. It may help identify treatment options or research opportunities.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must have ovarian, fallopian tube, or peritoneal cancer.
- Your cancer must be at an advanced stage (stage III or IV) at diagnosis.
- Your cancer can be newly diagnosed, persistent, or recurrent.
- You must have been diagnosed between 2018 and 2024.
- A stored tumor sample (from biopsy or surgery) must be available for testing.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the environment around ovarian cancer tumors to better understand the disease. It might help researchers find new ways to treat patients with advanced ovarian cancer.
This study will collect medical information from people with advanced ovarian, peritoneal, or fallopian tube cancer. The goal is to learn more about these cancers and improve future treatments.
This study looks for cancer DNA in your blood to understand advanced ovarian cancer better. It helps doctors see how the disease changes over time and may improve future treatments.
This study uses lab testing to create a “map” of ovarian cancer cells one cell at a time, to better understand the disease. It likely helps researchers learn which cell types are involved, using samples collected around your surgery.
This study looks at “biomarkers,” meaning measurable signals in blood and tumor tissue, in people with advanced ovarian-type cancers. The goal is to understand these markers and how they relate to the cancer, which may help guide future care.
This laboratory study uses ovarian cancer fluid collected during surgery to test possible new treatments on cancer and immune cells. It may help researchers find better treatment options in ovarian cancer.
Hear when a new Ovarian Cancer Stage III trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.